Syntheses of phosphoramidate protides of several 2',3'-dideoxy-3'-fluoroadenosine derivatives by treatment of the nucleoside with phosphorochloridates in the presence of pyridine and t-BuMgCl is described. Several of these protides showed significantly improved antiviral potency over the parent nucleoside against HIV and HBV. Especially marked was the improvement in potency of phosphoramidate protides of 2',3'-dideoxy-3'-fluoroadenosine against both HIV and HBV.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1081/NCN-120025242 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Study of Hydrolysis Kinetics and Synthesis of Single Isomer of Phosphoramidate ProTide-Acyclovir.
ACS Omega
November 2024
Thammasat University Research Unit in Drug, Health Product Development and Application (DHP-DA), Department of Pharmaceutical Sciences, Faculty of Pharmacy, Thammasat University, Pathum Thani 12120, Thailand.
Article Synopsis
- * Researchers synthesized and separated twelve novel single isomers of ProTide-ACV, finding that certain isomers convert faster during hydrolysis, revealing insights about their metabolic properties.
- * Preliminary tests indicated that three of the isomers had better antiviral effects against HSV-1 than standard acyclovir, underscoring the need for developing pure single isomers for more effective treatments in the future.
Development of 3'-Deoxy-3',4'-didehydro-nucleoside Prodrug Inhibitors of West Nile and Zika Viruses.
ACS Med Chem Lett
August 2024
Department of Medicinal Chemistry, University of Minnesota, 2231 Sixth Street SE, Minneapolis, Minnesota 55455, United States.
Article Synopsis
- The antiviral enzyme viperin produces ddhCTP, which is harmful to viral genomes, stopping their replication and showing broad antiviral effects.
- Researchers used ProTide technology to enhance the production of ddhCTP in cells, demonstrating effectiveness against West Nile virus and Zika virus.
- New variants of nucleosides were synthesized, with some showing significantly stronger antiviral activity, highlighting the potential for developing them into effective antiviral agents.
Regiochemical Analysis of the ProTide Activation Mechanism.
Biochemistry
July 2024
Department of Chemistry, Texas A&M University, College Station, Texas 77843, United States.
ProTides are nucleotide analogues used for the treatment of specific viral infections. These compounds consist of a masked nucleotide that undergoes enzymatic and spontaneous chemical transformations to generate a free mononucleotide that is ultimately transformed to the pharmaceutically active triphosphorylated drug. The three FDA approved ProTides are composed of a phosphoramidate (P-N) core coupled with a nucleoside analogue, phenol, and an l-alanyl carboxylate ester.
View Article and Find Full Text PDFAssessment of the therapeutic potential of a novel phosphoramidate acyclic nucleoside on induced hepatocellular carcinoma in rat model.
Life Sci
April 2024
Biotechnology Program, Basic and Applied Sciences Institute, Egypt-Japan University of Science and Technology (E-JUST), 21934 New Borg El-Arab City, Alexandria, Egypt; Biochemistry Department, Faculty of Science, Ain Shams University, 11566 Cairo, Egypt.
Aims: Hepatocellular Carcinoma (HCC) is renowned as a deadly primary cancer of hepatic origin. Sorafenib is the drug-of-choice for targeted treatment of unresectable end-stage HCC. Unfortunately, great proportion of HCC patients showed intolerance or unresponsiveness to treatment.
View Article and Find Full Text PDFA ProTide of AZT Shows Activity Against Human Papillomaviruses.
ChemMedChem
April 2024
Institute of Organic Chemistry, University of Stuttgart, Pfaffenwaldring 55, 70569, Stuttgart, Germany.
Infection by human papillomaviruses (HPV) can cause warts and tumors. So far, no small molecule antiviral has been approved for the treatment of infections with this DNA virus, although preclinical studies show activity for nucleosidic compounds, such as 9-(2-phosphonylmethoxy)ethylguanine (PMEG) or cidofovir. This prompted us to test new prodrug versions of the nucleoside analog 3'-azido-2',3'-dideoxythymidine (AZT), known to be active against reverse transcriptases and approved for the treatment of HIV.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!